Form 4: Biote Corp. Director Steven J. Heyer Acquires Stock Options
SEC Form 4 Filing
Director Steven J. Heyer acquired stock options in Biote Corp. on May 21, 2024.
Summary
- On May 21, 2024, Steven J. Heyer, a director of Biote Corp., acquired stock options to purchase 65,258 shares of Class A Common Stock at an exercise price of $5.57.
- These options vest on the earlier of May 21, 2025, or the day before the company's 2025 Annual Meeting of Stockholders, contingent upon continuous service.
- Following the transaction, Heyer directly owns 175,459 derivative securities.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing an insider transaction. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Future Outlook
The vesting of the options is contingent upon the Reporting Person's continuous service through the vesting date, indicating an incentive for continued involvement with the company.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions, providing transparency to the market regarding the actions of company directors. It is common for directors to receive stock options as part of their compensation.
Stakeholder Impact
- The transaction provides transparency to shareholders regarding insider activity.
- The vesting conditions incentivize the director's continued service to the company.
Key Dates
| Date | Description |
|---|---|
| 05/21/2024 | Date of transaction: Steven J. Heyer acquired stock options. |
| 05/21/2025 | Earliest vesting date for the stock options, contingent upon continuous service. |
| 05/20/2034 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.